NBIX 8-K 2026-11-02

NEUROCRINE BIOSCIENCES INC (NBIX) 8-K dated 2026-11-02 — accession 0000914475-26-000053.

NEUROCRINE BIOSCIENCES INC (NBIX) is a drug manufacturers - specialty & generic company listed on US.

NEUROCRINE BIOSCIENCES INC filed a 8-K on 2026-11-02. Accession 0000914475-26-000053.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported NBIX revenue for 2025-12-31 was $2.86B. Net income was $478.6M. Revenue was up 21.4% from 2024-12-31 to 2025-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 21.4.

Not investment advice. The NBIX SEC hub lists recent forms. The stock page is the research view.